It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

In its probe, SEBI observed that funds of credit balance clients were mis-utilized for meeting the obligations of debit balance clients and/or for its own purpose. The amount of misutilization ranged ...

Stock futures are mixed Thursday morning as investors react to a barrage of earnings reports from major companies and important economic indicators.

The U.S. GDP growth numbers will remain on TSX investors’ radar today, even as the market continues to assess the BoC’s and the Fed’s latest policy statements.

U.S. stock futures moved marginally higher on Thursday following the latest flurry of U.S. economic reports. Investors received the first reading on Q4 GDP. The data showed the U.S. economy expanded ...

"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products ...

Wall Street researchers have revised their price targets for Tesla stock — at present, no clear consensus has emerged.